# The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-first-in-class-potassium-competitive-acid-blocker-vonoprazan-fumarate/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hirotoshi Echizen |
| Citations | 201 |
| DOI | 10.1007/s40262-015-0326-7 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://link.springer.com/content/pdf/10.1007/s40262-015-0326-7.pdf |
| OpenAlex ID | https://openalex.org/W2172306046 |
| PMID | 26369775 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Hirotoshi Echizen](https://scholariq.org/researchers/hirotoshi-echizen/)

## Paper primary topic

- [Gastroesophageal reflux and treatments](https://scholariq.org/topics/gastroesophageal-reflux-and-treatments/)

## Paper topics

- [Gastroesophageal reflux and treatments](https://scholariq.org/topics/gastroesophageal-reflux-and-treatments/)
- [Helicobacter pylori-related gastroenterology studies](https://scholariq.org/topics/helicobacter-pylori-related-gastroenterology-studies/)
- [Pathogenesis and Treatment of Hiccups](https://scholariq.org/topics/pathogenesis-and-treatment-of-hiccups/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.